Management of anogenital lichen sclerosus.
Lichen sclerosus (LS) is a skin condition that affects genital and extra genital epithelia in both males and females of all ages and it may occur in association with other autoimmune disease. Currently, the first line effective treatment is an ultra-potent topical corticosteroid. The long-term sequelae of LS include scarring, malignancy, which is rare, and psychosexual disfunction, which is common.
Neill
S M
SM
St Johns Institute of Dermatology, St Thomas' Hospital, London, UK.
Ridley
C M
CM
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001004:Anus Diseases / Q000188:drug therapy / Q000523:psychology / Q000601:surgery; D002990:Clobetasol / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D018459:Lichen Sclerosus et Atrophicus / Q000188:drug therapy* / Q000523:psychology / Q000601:surgery; D008297:Male; D010409:Penile Diseases / Q000188:drug therapy / Q000523:psychology / Q000601:surgery; D020018:Sexual Dysfunctions, Psychological / Q000209:etiology / Q000628:therapy; D014845:Vulvar Diseases / Q000188:drug therapy / Q000523:psychology / Q000601:surgery
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D002990:Clobetasol